The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
News
-
Identification of narrow T-cell phenotype in coeliac disease
May 13, 2019 4:06 PM
Post.doc Asbjørn Christophersen has spear-headed the work that lead to identification of a narrow phenotype of gluten specific CD4+ T cells. This cell subset is also present in other autoimmune conditions and could be a target for future disease therapy.
-
Vacant positions
Feb. 21, 2019 8:54 AM
We have two vacant positions: one post.doc fellowship and one Ph.D fellowship. Apply within 13.March 2019.
-
Medisinbloggen: What is really gluten?
Dec. 20, 2018 11:14 PM
Gluten is a protein we have enjoyed for thousands of years. But if you have celiac disease, your body thinks that this protein is something dangerous. But what is gluten really?
-
Fine mapping of the wheat genome- one step closer to gluten free wheat
Sep. 6, 2018 7:56 AM
Through a massive, international collaborative effort, the entire genome of bread wheat has now been mapped. This makes it possible to in the future develop wheat strains that lack certain proteins, including the gluten proteins that are harmful for celiac disease patients.
Publications
- Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity Jan. 1, 9999 10:00 AM
- CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease Jan. 1, 9999 10:00 AM
- On the immune response to barley in celiac disease: Biased and public T-cell receptor usage to a barley unique and immunodominant gluten epitope Oct. 20, 2019 11:00 AM
